MyFinsight
Home
Blog
About
Contact
Download
Download image
Revenue From Contract
With Customer...
$130,424K
(67.12%↑ Y/Y)
Revenue From Contract
With Customer...
$130,424K
(67.12%↑ Y/Y)
Device Licensing And
Development
$5,603K
(64.41%↑ Y/Y)
Royalty
$240,681K
(43.10%↑ Y/Y)
Product
$130,424K
(67.12%↑ Y/Y)
Collaborative Agreements
$5,603K
(-69.92%↓ Y/Y)
Total revenues
$376,708K
(42.23%↑ Y/Y)
Operating income
$184,517K
(30.37%↑ Y/Y)
Investment and other
income, net
$1,318K
(-80.67%↓ Y/Y)
Total operating
expenses
$192,191K
(55.84%↑ Y/Y)
Income before income
tax expense
$180,327K
(25.38%↑ Y/Y)
Interest expense
$5,508K
(21.72%↑ Y/Y)
Cost of sales
$79,238K
(63.70%↑ Y/Y)
Selling, general and
administrative
$57,881K
(36.63%↑ Y/Y)
Amortization of intangibles
$29,512K
(66.15%↑ Y/Y)
Research and development
$25,560K
(72.71%↑ Y/Y)
Net income
$150,049K
(27.06%↑ Y/Y)
Income tax expense
$30,278K
(17.66%↑ Y/Y)
Back
Back
Income Statement
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)
source: myfinsight.com